Ranke, M. B., Feldt-Rasmussen, U., Bang, P., Baxter, R. C., Camacho-Hubner, C., Clemmons, D. R., Juul, A.
, Ørskov, H. & Strasburger, G. J. (2001).
How should insulin-like growth factor I be measured? A consensus statement.
Hormone Research,
55(Suppl. 2), 106-109.
Raschke, M., Kolbeck, S., Bail, H., Schmidmaier, G.
, Flyvbjerg, A., Lindner, T., Dahne, M., Roenne, I. A.
& Haas, N. D. H. D. (2001).
Homologous growth hormone accelerates healing of segmental bone defects.
Bone,
29(4), 368-373.
Rasmussen, L. M., Hansen, P. R., Nabipour, M. T.
, Olesen, P. L., Kristiansen, M. T.
& Ledet, T. (2001).
Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells.
Biochemical Journal,
360(PT 2), 363-370.
Ritzel, R., Schulte, M., Pørksen, N., Nauck, M. S., Holst, J. J., Juhl, C., Marz, W.
, Schmitz, O., Schmiegel, W. H. & Nauck, M. A. (2001).
Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance.
Diabetes,
50(4), 776-784.
Saenger, P., Wikland, K. A., Conway, G. S., Davenport, M.
, Gravholt, C. H., Hintz, R., Hovatta, O., Hultcrantz, M., Landin-Wilhelmsen, K., Lin, A., Lippe, B., Pasquino, A. M., Ranke, M. B., Rosenfeld, R. & Silberbach, M. (2001).
Recommendations for the diagnosis and management of Turner Syndrome.
Journal of Clinical Endocrinology and Metabolism,
86(7), 3061-3069.
Schmidmaier, G., Wildemann, B., Bail, H., Lucke, M., Fuchs, T., Stemberger, A.
, Flyvbjerg, A., Haas, N. P. & Raschke, M. (2001).
Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D,L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats.
Bone,
28(4), 341-350.
Schmitz, O., Juhl, C. B., Hollingdal, M., Veldhuis, J. D., Pørksen, N. & Pincus, S. M. (2001).
Irregular circulating insulin concentrations in type 2 diabetes mellitus: an inverse relationship between circulating free fatty acid and the disorderliness of an insulin time series in diabetic and healthy individuals.
Metabolism,
50(1), 41-46.